OUTCOMES AFTER HEART TRANSPLANTATION FOR AL COMPARED TO ATTR CARDIAC AMYLOIDOSIS

Light-chain (AL) cardiac amyloidosis (CA) has a worse prognosis than transthyretin (ATTR) CA. In this single-center study, we compared post heart transplant (OHT) survival for AL and ATTR amyloidosis, hypothesizing that these differences would persist post-OHT. Thirty-nine patients with CA (AL, n=18...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Transplant
Autores principales: Griffin, Jan M., Chiu, Leonard, Axsom, Kelly M., Bijou, Rachel, Clerkin, Kevin J., Colombo, Paolo, Cuomo, Margaret O., De Los Santos, Jeffeny, Fried, Justin A., Goldsmith, Jeff, Habal, Marlena, Haythe, Jennifer, Helmke, Stephen, Horn, Evelyn M., Latif, Farhana, Lee, Sun Hi, Lin, Edward F., Naka, Yoshifumi, Raikhelkar, Jayant, Restaino, Susan, Sayer, Gabriel T., Takayama, Hiroo, Takeda, Koji, Teruya, Sergio, Topkara, Veli, Tsai, Emily J., Uriel, Nir, Yuzefpolskaya, Melana, Farr, Maryjane A., Maurer, Mathew S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7744118/
https://ncbi.nlm.nih.gov/pubmed/32623785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ctr.14028
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares